文献速递核素与放射性配体治疗肿瘤 PET/CT

SIRT治疗前预测与治疗后实测剂量的定量比较:基于锥形束CT定义肿瘤与肝脏灌注区

Quantitative comparison of pre-treatment predictive and post-treatment measured dosimetry for selective internal radiation therapy using cone-beam CT for tumor and liver perfusion territory definition.
PubMed 文献 · EJNMMI Res · 2020-08-14

结果显示非肿瘤肝组织预测与实测平均剂量强相关(r=0.937),差值不超过11 Gy;肿瘤区相关性中等(r=0.623),平均差值-9.3 Gy。表明99mTc-MAA剂量学可预测非肿瘤肝照射以优化处方活度、避免肝毒性,但对肿瘤的预测一致性较差。

要点

  • 非肿瘤肝组织预测与实测平均剂量强相关(r=0.937),差值不超过11 Gy。
  • 肿瘤区预测与实测平均剂量相关性中等(r=0.623),平均差值-9.3 Gy。
  • 99mTc-MAA剂量学可预测非肿瘤肝照射,有助于优化活度以避免肝毒性。

核心结论

  • 99mTc-MAA预测剂量对非肿瘤肝组织照射具有预测价值,可用于处方优化活度以避免肝毒性。
  • 肿瘤区预测与实测吸收剂量一致性较非肿瘤组织差。

研究设计与样本

  • 预测剂量基于治疗前99mTc-MAA-SPECT,实测剂量基于治疗后90Y-TOF-PET。
  • 体素级剂量分布采用局部沉积模型导出,肝脏灌注区与肿瘤在99mTc-MAA工作期获取的增强CBCT图像上勾画。
  • 评估多个剂量体积直方图(DVH)参数及肝脏灌注区、非肿瘤与肿瘤区的平均剂量。

主要发现

  • 非肿瘤体积预测与实测平均剂量强相关(r=0.937),实测/预测平均剂量比第一、第二、第三四分位数分别为0.83、1.05、1.25。
  • 非肿瘤体积实测与预测平均剂量差值不超过11 Gy。
  • 肿瘤预测与实测平均剂量相关性中等(r=0.623),平均差值-9.3 Gy。
  • 肿瘤实测/预测平均剂量比中位数1.01,第一与第三四分位数分别为0.58和1.59。
  • 超过三分之二的肿瘤,预测吸收剂量能正确指示肿瘤剂量覆盖良好或剂量不足。

临床怎么用

  • 可利用99mTc-MAA剂量学预测非肿瘤肝组织照射,据此处方优化活度以降低肝毒性风险。
  • 对肿瘤区剂量预测一致性有限,解读肿瘤预测剂量时需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Selective internal radiation therapy (SIRT) is a promising treatment for unresectable hepatic malignancies. Predictive dose calculation based on a simulation using 99mTc-labeled macro-aggregated albumin (99mTc-MAA) before the treatment is considered as a potential tool for patient-specific treatment planning. Post-treatment dose measurement is mainly performed to confirm the planned absorbed dose to the tumor and non-tumor liver volumes. This study compared the predicted and measured absorbed dose distributions. METHODS: Thirty-one patients (67 tumors) treated by SIRT with resin microspheres were analyzed. Predicted and delivered absorbed dose was calculated using 99mTc-MAA-SPECT and 90Y-TOF-PET imaging. The voxel-level dose distribution was derived using the local deposition model. Liver perfusion territories and tumors have been delineated on contrast-enhanced CBCT images, which have been acquired during the 99mTc-MAA work-up. Several dose-volume histogram (DVH) parameters together with the mean dose for liver perfusion territories and non-tumoral and tumoral compartments were evaluated. RESULTS: A strong correlation between the predicted and measured mean dose for non-tumoral volume was observed (r = 0.937). The ratio of measured and predicted mean dose to this volume has a first, second, and third interquartile range of 0.83, 1.05, and 1.25. The difference between the measured and predicted mean dose did not exceed 11 Gy. The correlation between predicted and measured mean dose to the tumor was moderate (r = 0.623) with a mean difference of - 9.3 Gy. The ratio of measured and predicted tumor mean dose had a median of 1.01 with the first and third interquartile ranges of 0.58 and 1.59, respectively. Our results suggest that 99mTc-MAA-based dosimetry could predict under or over dosing of the non-tumoral liver parenchyma for almost all cases. For more than two thirds of the tumors, a predictive absorbed dose correctly indicated either good tumor dose coverage or under-dosing of the tumor. CONCLUSION: Our results highlight the predictive value of 99mTc-MAA-based dose estimation to predict non-tumor liver irradiation, which can be applied to prescribe an optimized activity aiming at avoiding liver toxicity. Compared to non-tumoral tissue, a poorer agreement between predicted and measured absorbed dose is observed for tumors.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Jafargholi Rangraz E, Tang X, Van Laeken C, et al. Quantitative comparison of pre-treatment predictive and post-treatment measured dosimetry for selective internal radiation therapy using cone-beam CT for tumor and liver perfusion territory definition. EJNMMI Res. 2020. PMID: 32797332. doi:10.1186/s13550-020-00675-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。